Working… Menu
Trial record 15 of 108 for:    "21-hydroxylase deficiency"

Safety, Pharmacokinetics and Pharmacodynamics of NBI-77860 in Adolescent Females With Congenital Adrenal Hyperplasia

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02349503
Recruitment Status : Withdrawn
First Posted : January 29, 2015
Last Update Posted : June 11, 2015
Information provided by (Responsible Party):
Neurocrine Biosciences

No Study Results Posted on for this Study
Study was withdrawn before participants were enrolled.
Recruitment Status : Withdrawn
Estimated Primary Completion Date : October 2015
Estimated Study Completion Date : October 2015